Insider trades
Steve Elms, Director of Adma Biologics ADMA, has filed 3 purchases and 8 sales on the open market. Over the past 12 months that comes to a net purchase of $217.4K. The latest trade was on 03/06.
Steve Elms
Director
- Company
- Adma Biologics ADMA
- First filing
- 23/03/08
- Trades
- 53 trades
- Buys / sales
- 3 / 8
- 12-month net buying
- $217.4K
- Last trade
- 03/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADMA | Open-market buy | 03/05–03/06 | 03/09 | 14,000 sh2 trades | $15.53avg. | $217,420 | +0.7% |
ADMA | Open-market sale | 25/06/12–25/06/16 | 25/06/16 | 425,621 sh3 trades | $20.74avg. | $8,829,333.47 | No record |
| Open-market buy | 24/12/23 | 24/12/26 | 11,085 sh | $3.20 | $35,472 | +3.5% | |
ADMA | Open-market sale | 24/03/18–24/03/19 | 24/03/19 | 461,716 sh2 trades | $6.07avg. | $2,803,741.19 | −17.9% |
ADMA | Open-market sale | 24/03/13–24/03/15 | 24/03/15 | 1,038,284 sh3 trades | $6.11avg. | $6,339,417.88 | −28.7% |
